Anti-HSP90 autoantibodies in sera of infertile women identify a dominant, conserved epitope EP6 (380-389) of HSP90 beta protein

Reproductive Biology and Endocrinology

Volumn 9, Issue , 2011, Pages

  Pires, Eusebio S ^a,c   Choudhury, Asmita K ^a   Idicula Thomas, Susan ^b   Khole, Vrinda V ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN REPRODUCTIVE HEALTH   (India)

^b Genetic Research Centre India   (India)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; EPITOPE; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 AUTOANTIBODY; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIGEN; OLIGOPEPTIDE; PEPTIDE FRAGMENT;

ALGORITHM; ANTIGEN BINDING; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DOT HYBRIDIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE INFERTILITY; HUMAN; IMMUNOREACTIVITY; NONHUMAN; NUCLEOTIDE SEQUENCE; OOCYTE; PREDICTION; PROTEIN CONFORMATION; PROTEIN STRUCTURE; STATISTICAL ANALYSIS; VALIDATION STUDY; ANIMAL; BLOOD; FEMALE; IMMUNOLOGY; RABBIT;

ORYCTOLAGUS CUNICULUS;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; FEMALE; HSP90 HEAT-SHOCK PROTEINS; HUMANS; IMMUNODOMINANT EPITOPES; INFERTILITY, FEMALE; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; RABBITS;

EID: 79251584637     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-9-16     Document Type: Article

References (54)

1. Von Muhlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995, 24(5):323. 10.1016/S0049-0172(95)80004-2, 7604300.
2. Luborsky J. Ovarian autoimmune disease and ovarian autoantibodies. J Women's Health Gend Based Med 2002, 11(7):585-599.
3. Forges T, Monnier-Barbarino P, Faure GC, Bene MC. Autoimmunity and antigenic targets in ovarian pathology. Hum Reprod Update 2004, 10(2):163-175. 10.1093/humupd/dmh014, 15073145.
4. deMoraes-Ruehsen H, Jones GS. Premature ovarian failure. Fertil Steril 1967, 18(4):440-461.
5. Barbarino-Monnier P, Gobert B, Guillet-Rosso F, Bene MC, Landes P, Faure G. Antiovary antibodies, repeated attempts, and outcome of in vitro fertilization. Fertil Steril 1991, 56(5):928-932.
6. Coulam CB, Kempers RD, Randall RV. Premature ovarian failure: evidence for the autoimmune mechanism. Fertil Steril 1981, 36(2):238-240.
7. Coulam CB. The prevalence of autoimmune disorders among patients with primary ovarian failure. Am J Reprod Immunol 1983, 4(2):63-66.
8. Novosad JA, Kalantaridou SN, Tong ZB, Nelson LM. Ovarian antibodies as detected by indirect Immunofluorescence are unreliable in the diagnosis of autoimmune premature ovarian failure: a controlled evaluation. BMC Womens Health 2003, 3(1):2. 10.1186/1472-6874-3-2, 153539, 12694633.
9. Wheatcroft NJ, Salt C, Milford-Ward A, Cooke ID, Weetman AP. Identification of ovarian antibodies by Immunofluorescence, enzyme linked immunosorbent assay or immunoblotting in premature ovarian failure. Hum Reprod 1997, 12(12):2617-2622. 10.1093/humrep/12.12.2617, 9455824.
10. Pires ES, Parte PP, Meherji PK, Khan SA, Khole VV. Naturally occurring anti-albumin antibodies are responsible for false positivity in diagnosis of autoimmune premature ovarian failure. J Histochem Cytochem 2006, 54(4):397-405. 10.1369/jhc.5A6778.2005, 16286665.
11. Pires ES, Meherji PK, Vaidya RR, Parikh FR, Ghosalkar MN, Khole VV. Specific and sensitive immunoassays detect multiple anti-ovarian antibodies in women with infertility. J Histochem Cytochem 2007, 55(12):1181-1190. 10.1369/jhc.7A7259.2007, 17652265.
12. Pires ES, Khole VV. A block in the road to fertility: autoantibodies to heat-shock protein 90-beta in human ovarian autoimmunity. Fertil Steril 2009, 92(4):1395-1409. 10.1016/j.fertnstert.2008.08.068, 19022436.
13. Faulds G, Conroy S, Madaio M, Isenberg D, Latchman D. Increased levels of antibodies to heat shock proteins with increasing age in MRL/MP-LPR mice. Br J Rheumatol 1995, 34(7):610-615. 10.1093/rheumatology/34.7.610, 7670777.
14. Hayem G, De Bandt M, Palazzo E, Roux S, Combe B, Eliaou JF, Sany J, Kahn MF, Meyer O. Anti-heat shock protein 70kDa and 90-kd antibodies in serum of patients with rheumatoid arthritis. Ann Rheum Dis 1999, 58:292-296.
15. Trieb K, Gerth R, Holzer G, Grohs JG, Berger P, Kotz R. Antibodies to heat shock protein 90 in osteosarcoma patients correlate with response to neoadjuvant chemotherapy. Br J Cancer 2000, 82(1):85-87. 10.1054/bjoc.1999.0881, 2363193, 10638971.
16. Vidal CI, Mintz PJ, Lu K, Ellis LM, Manenti L, Giavazzi R, Gershenson DM, Broaddus R, Liu J, Arap W, Pasqualini R. An HSP90-mimic peptide revealed by fingerprinting the pool of antibodies from ovarian cancer patients. Oncogene 2004, 23(55):8859-8867. 10.1038/sj.onc.1208082, 15480432.
17. Panicker RC, Huang X, Yao SQ. Recent advances in peptide-based microarray technologies. Comb Chem High Throughput Screen 2004, 7(6):547-556.
18. Gomara MJ, Haro I. Synthetic peptides for the immunodiagnosis of human diseases. Curr Med Chem 2007, 14(5):531-546. 10.2174/092986707780059698, 17346145.
19. Meloen RH, Puijk WC, Langeveld JP, Langedijk JP, Timmerman P. Design of synthetic peptides for diagnostics. Curr Protein Pept Sci 2003, 4(4):253-260. 10.2174/1389203033487144, 14529532.
20. Hans D, Young PR, Fairlie DP. Current status of short synthetic peptides as vaccines. Med Chem 2006, 2(6):627-646.
21. Parker JM, Guo D, Hodges RS. New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry 1986, 25(19):5425-5432. 10.1021/bi00367a013, 2430611.
22. Hopp TP, Woods KR. Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci USA 1981, 78(6):3824-3828. 10.1073/pnas.78.6.3824, 319665, 6167991.
23. Emini EA, Hughes JV, Perlow DS, Boger J. Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol 1985, 55(3):836-839. 255070, 2991600.
24. Pellequer JL, Westhof E, Van Regenmortel MH. Correlation between the location of antigenic sites and the prediction of turns in proteins. Immunol Lett 1993, 36(1):83-99. 10.1016/0165-2478(93)90072-A, 7688347.
25. Karplus PA, Schulz GE. Prediction of Chain Flexibility in Proteins- a tool for the selection of peptide antigens. Naturwissenschaften 1985, 72:212-213.
26. Kolaskar AS, Tongaonkar PC. A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 1990, 276(1):172-174. 10.1016/0014-5793(90)80535-Q, 1702393.
27. Laemelli UK. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1970, 227(5259):680-685. 10.1038/227680a0, 5432063.
28. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gel to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979, 76(9):4350-4354. 10.1073/pnas.76.9.4350, 411572, 388439.
29. IEBD Analysis Resource IEBD Analysis Resource., http://tools.immuneepitope.org/tools/bcell/iedb_input
30. Larsen JE, Lund O, Nielsen M. Improved method for predicting linear B-cell epitopes. Immunome Res 2006, 24(2):2.
31. Saha S, Raghava GP. Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins 2006, 65(1):40-48. 10.1002/prot.21078, 16894596.
32. BLAST Assembled RefSeq Genomes BLAST Assembled RefSeq Genomes., http://www.ncbi.nlm.nih.gov/BLAST/
33. ClustalW2 - Multiple Sequences Alignment ClustalW2 - Multiple Sequences Alignment., http://www.ebi.ac.uk/Tools/clustalw2/
34. DeLano WL. The PyMOL molecular graphics system. 2002, http://www.pymol.org
35. Altman DG, Bland JM. Statistics notes: Quartiles, quintiles, centiles, and other quantiles. Br Med J 1994, 309(6960):996.
36. Jeffoate SL. Interpretation of single progesterone measurement in diagnosis of anovulation and defective luteal phase. Br Med J 1984, 288(6420):864. Clin Res Ed.
37. Freeman BC, Morimoto RI. The human cytosolic molecular chaperones hsp90, hsp70 (hsc70) and hdj-1 have distinct roles in recognition of a non-native protein and protein refolding. EMBO J 1996, 15(12):2969-2979. 450238, 8670798.
38. Sreedhara AM, Kalmar E, Csermely P, Shen YF. Hsp90 isoforms: functions, expression and clinical importance. FEBS Letters 2004, 562(1-3):11-15. 10.1016/S0014-5793(04)00229-7, 15069952.
39. Calvert ME, Digilio LC, Herr JC, Coonrod SA. Oolemmal proteomics-identification of highly abundant heat shock proteins and molecular chaperones in the mature mouse egg and their localization on the plasma membrane. Reprod Biol Endocrinol 2003, 1:27. 10.1186/1477-7827-1-27, 151799, 12646049.
40. Ohsako S, Bunick D, Hayashi Y. Immunocytochemical observation of the 90 KD heat shock protein (HSP90): high expression in primordial and pre-meiotic germ cells of male and female rat gonads. J Histochem Cytochem 1995, 43(1):67-7.
41. Voss AK, Thomas T, Gruss P. Mice lacking HSP90beta fail to develop a placental labyrinth. Development 2000, 127(1):1-11.
42. UniProtKB UniProtKB., http://www.uniprot.org/uniprot/P08238
43. Wright L, Barril X, Dymock B, Sheridan L, Surgenor A, Beswick M, Drysdale M, Collier A, Massey A, Davies N, et al. Structure-activity relationships in purine-based inhibitor binding to HSP90 isoforms. Chem Biol 2004, 11(6):775-785. 10.1016/j.chembiol.2004.03.033, 15217611.
44. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997, 25(17):3389-3402. 10.1093/nar/25.17.3389, 146917, 9254694.
45. Alix AJ. Predictive estimation of protein linear epitopes by using the program PEOPLE. Vaccine 1999, 18(3):311-314. 10.1016/S0264-410X(99)00329-1, 10506656.
46. Carugo O. Predicting residue solvent accessibility from protein sequence by considering the sequence environment. Protein Eng 2000, 13(9):607-609. 10.1093/protein/13.9.607, 11054454.
47. Pashov A, Kenderov A, Kyurkchiev S, Kehayov I, Hristova S, Lacroix-Desmazes S, Giltiay N, Varamballi S, Kazatchkine MD, Kaveri SV. Autoantibodies to heat shock protein 90 in the human natural antibody repertoire. Int Immunol 2002, 14(5):453-461. 10.1093/intimm/14.5.453, 11978775.
48. Pires ES, Khole VV. Anti- ovarian antibodies: Specificity, prevalence, multiple antigenicity and significance in human ovarian autoimmunity. Curr Paradigm of Reprod Immunol 2009, 159-190. Research signpost Trivandrum, India, ISBN: 978-81-308-0373-9.
49. Pires ES. Multiplicity of molecular and cellular targets in human ovarian autoimmunity: an update. J Assist Reprod Genet 2010, 27(9):519-524. 10.1007/s10815-010-9440-5, 20521094.
50. Pires ES, Parikh F, Mande P, Uttamchandani S, Savkar S, Khole V. Can anti-ovarian antibody testing be useful in an IVF-ET clinic?. J Assist Reprod Genet 2010,
51. Ruiz-Arguelles A, Alarcon-Segovia D. Penetration of autoantibodies into living cells, 2000. Isr Med Assoc J 2001, 3(2):121-126.
52. Eustace BK, Jay DG. Extracellular roles for the molecular chaperone, HSP90. Cell cycle 2004, 3(9):1098-1100. 10.4161/cc.3.9.1088, 15326368.
53. Sidera K, Gaitanou M, Stellas D, Matsas R, Patsavoudi E. A Critical Role for HSP90 in Cancer Cell Invasion Involves Interaction with the Extracellular Domain of HER-2. J Biol Chem 2008, 283(4):2031-2041. 10.1074/jbc.M701803200, 18056992.
54. Neuer A, Mele C, Liu HC, Rosenwaks Z, Witkin SS. Monoclonal antibodies to mammalian heat shock proteins impair mouse embryo development in vitro. Hum Reprod 1998, 13(4):987-990. 10.1093/humrep/13.4.987, 9619559.